|
Ec-naprosynDrug - Ec-naprosyn The trade name of the product as shown on the labeling.
Dosage -
TABLET, DELAYED RELEASE; ORAL
Active Ingredient(s) -
Naproxen
Strength -
500MG
Applicant -
ROCHE PALO
New Drug Application (NDA) Number -
020067
Product Number -
003
Therapeutic Equivalence (TE) Code -
AB
Approval Date -
Oct 14, 1994
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Roche Palo Alto Llc
Ec-naprosyn
Ec-naprosyn 500mg Tablet, Delayed Release; Oral
Naphcon Forte 0.1% Solution/drops; Ophthalmic Opcon 0.1% Solution/drops; Ophthalmic Vasocon 0.1% Solution/drops; Ophthalmic Naphcon-a 0.025%;0.3% Solution/drops; Ophthalmic Opcon-a 0.02675%;0.315% Solution/drops; Ophthalmic Visine-a 0.025%;0.3% Solution/drops; Ophthalmic Naprosyn 25mg/ml Suspension; Oral Naproxen 25mg/ml Suspension; Oral Ec-naprosyn 375mg Tablet, Delayed Release; Oral NewDrugInformation |